… to documented therapeutic trials of at least two antidepressants of … to clinical practice without
larger, randomised studies. Such … major depression. Arch Gen Psychiatry 2006; 63: 856–64. …

… of change during the study P < .… study was not a controlled, randomized trial and the
medications were stable for 3 to 4 weeks; therefore, it was possible that the delayed antidepressant …

… Despite this, current conventional antidepressant treatment faces … has a medical emergency
or a change in the patient’s … the study protocol of a randomized double-blind controlled trial …

… The primary outcome was change in MADRS score. Hypothesis-… existing data for the
antidepressant effect of individual … There was a greater frequency of early termination secondary to …

… was also the first day of the double-blind treatment period and … The primary efficacy endpoint
was the change in HAMD 17 … ER tablets were similar to these SSRIs and better than other …

… In the present study, we investigated the antidepressant … the change in depression severity,
as indicated by percent … all clinical trials for major depressive disorder, our study relied on …

… -on simvastatin to standard antidepressant medication with … secondary outcome variables
change scores in patients’ self-… patients: a double-blind, placebo-controlled, randomized trial. …

… compared to placebo at a regular or as-needed dosing … selective serotonin reuptake inhibitors
(SSRIs) and serotonin and … , with 51 switching to TRAM/DKP 75/25 mg and 51 switching to …

… of adults with moderate-to-severe levels of MDD. A supportive … reaction to ketamine is
needed for an antidepressant response. … in MADRS change scores observed in our study is also …

… of antidepressant augmentation with minocycline in patients with … randomised trials (RCTs)
have assessed the augmentation therapy with minocycline 200 mg/day in MDD: one study …